Effects of Somatostatin Analogs and Dopamine Agonists on Insulin-Like Growth Factor 2-Induced Insulin Receptor Isoform A Activation by Gastroenteropancreatic Neuroendocrine Tumor Cells-Reference-Cited by-同舟云学术

Effects of Somatostatin Analogs and Dopamine Agonists on Insulin-Like Growth Factor 2-Induced Insulin Receptor Isoform A Activation by Gastroenteropancreatic Neuroendocrine Tumor Cells

Published:2016 Issue:6 Volume:103 Page:815-825
ISSN:0028-3835
Container-title:Neuroendocrinology
language:en
Short-container-title:Neuroendocrinology

Author:

van Adrichem Roxanne C.S.,de Herder Wouter W.^ORCID,Kamp Kimberly,Brugts Michael P.,de Krijger Ronald R.,Sprij-Mooij Diana M.,Lamberts Steven W.J.,van Koetsveld Peter M.,Janssen Joseph A.M.J.L.,Hofland Leo J.

Publisher

S. Karger AG

Subject

Cellular and Molecular Neuroscience,Endocrine and Autonomic Systems,Endocrinology,Endocrinology, Diabetes and Metabolism

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring Emerging Therapeutic Targets and Opportunities in Neuroendocrine Tumors: Updates on Receptor Tyrosine Kinases;Receptors;2024-04-05

2. Somatostatin-Dopamine Chimeric Molecules in Neuroendocrine Neoplasms;Journal of Clinical Medicine;2021-02-01

3. Efficacy of a Novel Second-Generation Somatostatin-Dopamine Chimera (TBR-065) in Human Medullary Thyroid Cancer: A Preclinical Study;Neuroendocrinology;2020-10-19

4. Biological and Biochemical Basis of the Differential Efficacy of First and Second Generation Somatostatin Receptor Ligands in Neuroendocrine Neoplasms;International Journal of Molecular Sciences;2019-08-13

5. Effects of novel somatostatin-dopamine chimeric drugs in 2D and 3D cell culture models of neuroendocrine tumors;Endocrine-Related Cancer;2019-06